Detalhe da pesquisa
1.
Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.
EBioMedicine
; 27: 61-70, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269041
2.
Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C.
PLoS One
; 8(12): e82380, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24312658
3.
Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin.
PLoS One
; 7(2): e31177, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22363572
4.
Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.
Vaccine
; 25(9): 1593-606, 2007 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-17178179
5.
Comparative antigenicity and immunogenicity of hepadnavirus core proteins.
J Virol
; 79(21): 13641-55, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16227284
6.
Combinatorial approach to hepadnavirus-like particle vaccine design.
J Virol
; 79(21): 13656-66, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16227285